Effect of AV3V lesions on development of DOCA-Salt hypertension and vascular Na+-pump activity

Emel Songu-Mize, Steven L. Bealer, Robert William Caldwell

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

We studied the effects of anteroventral third ventricle (AV3V) lesions on the vascular Na+-pump activity of deoxycorticosterone acetate-salt (DOCA-salt) treated rats. Blood pressures and Na+-pump activity of the isolated tail arteries, measured as ouabain-sensitive36Rb+-uptake, were determined in untreated control rats, DOCA-salt treated rats, rats with AV3V lesions, and rats with AV3V lesions which were treated with DOCA-salt. Control rats receiving DOCA treatment developed higher blood pressures than rats receiving no DOCA treatment. Placement of AV3V lesions prior to administration of DOCA prevented the increase in blood pressure. Vascular Na+-pump activity in the DOCA-treated group was reduced by 20% compared to all other groups. The AV3V lesions prevented the suppression of Na+-pump activity caused by DOCA treatment. Suppression of vascular Na+-pump activity was due to a humoral substance since Na+-punip activity of tail arteries from control rats incubated in plasma from DOCA-salt treated rats was suppressed by 25% when compared to those incubated in control plasma. Our findings support the hypothesis that a circulating pressor substance is at least partially responsible for the development of DOCA-salt hypertension and that the mechanism by which AV3V lesions prevent DOCA hypertension may be through the interruption of secretion, transport, or synthesis of this factor.

Original languageEnglish (US)
Pages (from-to)575-580
Number of pages6
JournalHypertension
Volume4
Issue number5
DOIs
StatePublished - Jan 1 1982
Externally publishedYes

Fingerprint

Desoxycorticosterone Acetate
Blood Vessels
Salts
Desoxycorticosterone
Hypertension
Acetates
Tail
Arteries
Blood Pressure
Third Ventricle
Ouabain

Keywords

  • Av3V lesion
  • Blood pressure
  • Hypertension
  • Na-pump activity
  • Rb-uptake
  • Tail artery

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Effect of AV3V lesions on development of DOCA-Salt hypertension and vascular Na+-pump activity. / Songu-Mize, Emel; Bealer, Steven L.; Caldwell, Robert William.

In: Hypertension, Vol. 4, No. 5, 01.01.1982, p. 575-580.

Research output: Contribution to journalArticle

@article{4daca7e246fa4ca7a186ffb1fc09546c,
title = "Effect of AV3V lesions on development of DOCA-Salt hypertension and vascular Na+-pump activity",
abstract = "We studied the effects of anteroventral third ventricle (AV3V) lesions on the vascular Na+-pump activity of deoxycorticosterone acetate-salt (DOCA-salt) treated rats. Blood pressures and Na+-pump activity of the isolated tail arteries, measured as ouabain-sensitive36Rb+-uptake, were determined in untreated control rats, DOCA-salt treated rats, rats with AV3V lesions, and rats with AV3V lesions which were treated with DOCA-salt. Control rats receiving DOCA treatment developed higher blood pressures than rats receiving no DOCA treatment. Placement of AV3V lesions prior to administration of DOCA prevented the increase in blood pressure. Vascular Na+-pump activity in the DOCA-treated group was reduced by 20{\%} compared to all other groups. The AV3V lesions prevented the suppression of Na+-pump activity caused by DOCA treatment. Suppression of vascular Na+-pump activity was due to a humoral substance since Na+-punip activity of tail arteries from control rats incubated in plasma from DOCA-salt treated rats was suppressed by 25{\%} when compared to those incubated in control plasma. Our findings support the hypothesis that a circulating pressor substance is at least partially responsible for the development of DOCA-salt hypertension and that the mechanism by which AV3V lesions prevent DOCA hypertension may be through the interruption of secretion, transport, or synthesis of this factor.",
keywords = "Av3V lesion, Blood pressure, Hypertension, Na-pump activity, Rb-uptake, Tail artery",
author = "Emel Songu-Mize and Bealer, {Steven L.} and Caldwell, {Robert William}",
year = "1982",
month = "1",
day = "1",
doi = "10.1161/01.HYP.4.5.575",
language = "English (US)",
volume = "4",
pages = "575--580",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Effect of AV3V lesions on development of DOCA-Salt hypertension and vascular Na+-pump activity

AU - Songu-Mize, Emel

AU - Bealer, Steven L.

AU - Caldwell, Robert William

PY - 1982/1/1

Y1 - 1982/1/1

N2 - We studied the effects of anteroventral third ventricle (AV3V) lesions on the vascular Na+-pump activity of deoxycorticosterone acetate-salt (DOCA-salt) treated rats. Blood pressures and Na+-pump activity of the isolated tail arteries, measured as ouabain-sensitive36Rb+-uptake, were determined in untreated control rats, DOCA-salt treated rats, rats with AV3V lesions, and rats with AV3V lesions which were treated with DOCA-salt. Control rats receiving DOCA treatment developed higher blood pressures than rats receiving no DOCA treatment. Placement of AV3V lesions prior to administration of DOCA prevented the increase in blood pressure. Vascular Na+-pump activity in the DOCA-treated group was reduced by 20% compared to all other groups. The AV3V lesions prevented the suppression of Na+-pump activity caused by DOCA treatment. Suppression of vascular Na+-pump activity was due to a humoral substance since Na+-punip activity of tail arteries from control rats incubated in plasma from DOCA-salt treated rats was suppressed by 25% when compared to those incubated in control plasma. Our findings support the hypothesis that a circulating pressor substance is at least partially responsible for the development of DOCA-salt hypertension and that the mechanism by which AV3V lesions prevent DOCA hypertension may be through the interruption of secretion, transport, or synthesis of this factor.

AB - We studied the effects of anteroventral third ventricle (AV3V) lesions on the vascular Na+-pump activity of deoxycorticosterone acetate-salt (DOCA-salt) treated rats. Blood pressures and Na+-pump activity of the isolated tail arteries, measured as ouabain-sensitive36Rb+-uptake, were determined in untreated control rats, DOCA-salt treated rats, rats with AV3V lesions, and rats with AV3V lesions which were treated with DOCA-salt. Control rats receiving DOCA treatment developed higher blood pressures than rats receiving no DOCA treatment. Placement of AV3V lesions prior to administration of DOCA prevented the increase in blood pressure. Vascular Na+-pump activity in the DOCA-treated group was reduced by 20% compared to all other groups. The AV3V lesions prevented the suppression of Na+-pump activity caused by DOCA treatment. Suppression of vascular Na+-pump activity was due to a humoral substance since Na+-punip activity of tail arteries from control rats incubated in plasma from DOCA-salt treated rats was suppressed by 25% when compared to those incubated in control plasma. Our findings support the hypothesis that a circulating pressor substance is at least partially responsible for the development of DOCA-salt hypertension and that the mechanism by which AV3V lesions prevent DOCA hypertension may be through the interruption of secretion, transport, or synthesis of this factor.

KW - Av3V lesion

KW - Blood pressure

KW - Hypertension

KW - Na-pump activity

KW - Rb-uptake

KW - Tail artery

UR - http://www.scopus.com/inward/record.url?scp=0020454197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020454197&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.4.5.575

DO - 10.1161/01.HYP.4.5.575

M3 - Article

VL - 4

SP - 575

EP - 580

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 5

ER -